STE
$220.13
STERIS plc provides infection prevention products and services worldwide.
Recent News
A Look At STERIS (STE) Valuation After Recent Share Price Weakness
What stands out about STERIS right now STERIS (STE) has drawn attention after a stretch of weaker share performance, with the stock down about 14% over the past month and 15% over the past 3 months, despite ongoing revenue and net income growth. See our latest analysis for STERIS. At a share price of $214.57, STERIS has a 1 day share price return of 1.05%, a 30 day share price return of 13.60%, and a 1 year total shareholder return of 4.87%. Recent weakness therefore contrasts with a still...
Is STERIS Stock Underperforming the Nasdaq?
STERIS has underperformed the Nasdaq over the past year, but analysts are cautiously optimistic about the stock’s prospects.
3 Healthcare Stocks We Think Twice About
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have seen decent returns lately as healthcare stocks were up 4.1% over the past six months, almost identical to the S&P 500.
Bio-Techne, Bruker, DexCom, STERIS, and Teleflex Shares Plummet, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
Steris (STE) Down 2.2% Since Last Earnings Report: Can It Rebound?
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.